LYNPARZA 150MG TABLET

Form: Tablets

Pack Size: 8 TABLETS

Marketed by: ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV)

MRP: ₹41025.00

ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV): Lynparza 150MG Tablet, 8 tablets, salt olaparib 150mg. Its MRP stays at Rs 41,025 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 31,257.14. Group: PARP inhibitor (targeted therapy). Same salt is also supplied by Abbott, Cipla, Dr. Reddy's, Emcure, Glenmark and others. Handling/counselling: tablet and capsule forms are not interchangeable mg for mg; check the prescription carefully. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.